Abstract
Several lines of evidence support the relevance of reactive oxygen species (ROS) in vitiligo, but the exact role of glycation and oxidation of macromolecules needs to be better addressed. To investigate the involvement of advanced oxidation protein products (AOPPs) and advanced glycation end-products (AGEs), we performed a case–control association study by spectrofluorimetry and spectrophotometry, in 47 patients with non-segmental generalized vitiligo and 47 age- and sex-matched controls. Significantly higher levels of both AOPPs (p < 0.0001) and AGEs (p < 0.0001) were observed in vitiligo patients compared to healthy controls. In vitiligo patients, AGEs and AOPPs serum levels were directly associated with extension, duration of vitiligo, and disease activity. ROS, and in particular AGEs and AOPPs, could represent one of the main biomarkers to assess the onset and progression of vitiligo, due to the potential role as direct inducers of cell damage and also as autoimmunity triggers. Further longitudinal studies involving larger cohorts of patients are required to elucidate the role of oxidation products in the pathogenesis of vitiligo.
References
Arican O, Kurutas EB (2008) Oxidative stress in the blood of patients with active localized vitiligo. Acta Dermatovenerol Alp Pannonica Adriat 17:12–16
Baskol G, Demir H, Baskol M, Kilic E, Ates F, Karakukcu C, Ustdal M (2006) Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis. Cell Biochem Funct 24:307–311
Baskol G, Gumus K, Oner A, Arda H, Karakucuk S (2008) The role of advanced oxidation protein products and total thiols in diabetic retinopathy. Eur J Ophthalmol 18:792–798
Bellei B, Pitisci A, Ottaviani M, Ludovici M, Cota C, Luzi F, Dell’Anna ML, Picardo M (2013) Vitiligo: a possible model of degenerative diseases. PLoS One 8:e59782
Bickers DR, Athar M (2006) Oxidative stress in the pathogenesis of skin disease. J Investig Dermatol 126:2565–2575
Cannavò SP, Borgia F, Vaccaro M, Guarneri F, Magliolo E, Guarneri B (2002) Pretibial myxoedema associated with Hashimoto’s thyroiditis. J Eur Acad Dermatol Venereol 16:625–627
Cristani M, Speciale A, Saija A, Gangemi S, Minciullo PL, Cimino F (2016) Circulating advanced oxidation protein products as oxidative stress biomarkers and progression mediators in pathological conditions related to inflammation and immune dysregulation. Curr Med Chem 23:3862–3882
Damasiewicz-Bodzek A, Wielkoszyński T (2012) Advanced protein glycation in psoriasis. J Eur Acad Dermatol Venereol 26:172–179
Davies CA, Herrick AL, Cordingley L, Freemont AJ, Jeziorska M (2009) Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis. Rheumatology (Oxford) 48:876–882
de Macedo GM, Nunes S, Barreto T (2016) Skin disorders in diabetes mellitus: an epidemiology and physiopathology review. Diabetol Metab Syndr 8:63
Di Dalmazi G, Hirshberg J, Lyle D, Freij JB, Caturegli P (2016) Reactive oxygen species in organ-specific autoimmunity. Autoimmun Highlights 7:11
Di Lorenzo G, Minciullo PL, Leto-Barone MS, La Piana S, La Porta G, Saija A, Gangemi S (2013) Differences in the behavior of advanced glycation end products and advanced oxidation protein products in patients with allergic rhinitis. J Investig Allergol Clin Immunol 23:101–106
Ezzedine K, Eleftheriadou V, Whitton M, van Geel N (2015) Vitiligo. Lancet 386:74–84
Gangemi S, Minciullo PL, Magliacane D, Saitta S, Loffredo S, Saija A, Cristani M, Marone G, Triggiani M (2015) Oxidative stress markers are increased in patients with mastocytosis. Allergy 70:436–442
Gey A, Diallo A, Seneschal J, Léauté-Labrèze C, Boralevi F, Jouary T, Taieb A, Ezzedine K (2013) Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms. Br J Dermatol 168:756–761
Güntaş G, Engin B, Ekmekçi ÖB, Kutlubay Z, Ekmekci H, Songür A, Uzunçakmak TK, Vehid HE, Serdaroğlu S, Tüzün Y, Uzun H et al (2015) Evaluation of advanced oxidation protein products, prooxidant-antioxidant balance, and total antioxidant capacity in untreated vitiligo patients. Ann Dermatol 27:178–183
Jain A, Mal J, Mehndiratta V, Chander R, Patra SK (2011) Study of oxidative stress in vitiligo. Indian J Clin Biochem 26:78–81
Jian Z, Li K, Song P, Zhu G, Zhu L, Cui T, Liu B, Tang L, Wang X, Wang G, Gao T, Li C (2014) Impaired activation of the Nrf2-ARE signaling pathway undermines H2O2-induced oxidative stress response: a possible mechanism for melanocyte degeneration in vitiligo. J. Investig Dermatol 134:2221–2230
Jimbow K, Chen H, Park JS, Thomas PD (2001) Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol 144:55–65
Kadam DP, Suryakar AN, Ankush RD, Kadam CY, Deshpande KH (2010) Role of oxidative stress in various stages of psoriasis. Indian J Clin Biochem 25:388–392
Khan R, Satyam A, Gupta S, Sharma VK, Sharma A (2009) Circulatory levels of antioxidants and lipid peroxidation in Indian patients with generalized and localized vitiligo. Arch Dermatol Res 301:731–737
Laddha NC, Dwivedi M, Mansuri MS, Singh M, Patel HH, Agarwal N, Shah AM, Begum R (2014) Role of oxidative stress and autoimmunity in onset and progression of vitiligo. Exp Dermatol 23:352–353
Musolino C, Allegra A, SaijaA Alonci A, Russo S, Spatari G, Penna G, Gerace D, Cristani M, David A, Saitta S, Gangemi S (2012) Changes in advanced oxidation protein products, advanced glycation end products, and s nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia. Clin Biochem 45:1439–1443
Naziroglu M, Kokcam I (2000) Antioxidants and lipid peroxidation status in the blood of patients with alopecia. Cell Biochem Funct 18:169–173
Naziroglu M, Kokcam I, Simsek H, Karakilcik AZ (2003) Lipid peroxidation and antioxidants in plasma and red blood cells from patients with pemphigus vulgaris. J Basic Clin Physiol Pharmacol 14:31–42
Ozel Turkcu U, Tekin NS, Edgunlu TG, Karakas SC, Oner S (2013) The association of Foxo3a gene polymorphisms with serum Foxo3a levels and oxidative stress markers in vitiligo patients. Gene. doi:10.1016/S0378-1119(13)00039-5
Prignano F, Pescitelli L, Becatti M, Di Gennaro P, Fiorillo C, Taddei N, Lotti T (2009) Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. J Dermatol Sci 54:157–167
Ruggeri RM, Vicchio TM, Cristani M, Certo R, Caccamo D, Alibrandi A, Giovinazzo S, Saija A, Campennì A, Trimarchi F, Gangemi S (2016) Oxidative stress and advanced glycation end products (AGEs) in Hashimoto’s thyroiditis. Thyroid 26:504–511
Sandoval-Cruz M, García-Carrasco M, Sánchez-Porras R, Mendoza-Pinto C, Jiménez-Hernández M, Munguía-Realpozo P, Ruiz-Argüelles A (2011) Immunopathogenesis of vitiligo. Autoimmun Rev 10:762–765
Schallreuter KU, Moore J, Wood JM, Beazley WD, Peters EM, Marles LK, Behrens-Williams SC, Dummer R, Blau N, Thöny B (1999) In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc Soc Investig Dermatol Inc Eur Soc Dermatol Res 4:91–96
Servettaz A, Guilpain P, Goulvestre C, Chéreau C, Hercend C, Nicco C, Guillevin L, Weill B, Mouthon L, Batteux F (2007) Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis. Ann Rheum Dis 66:1202–1209
Spatari G, Saitta S, Cimino F, Sapienza D, Quattrocchi P, Carrieri M, Barbaro M, Saija A, Gangemi S (2012) Increased serum levels of advanced oxidation protein products and glycation end products in subjects exposed to low-dose benzene. Int J Hyg Environ Health 215:389–392
Sravani PV, Babu NK, Gopal KV, Rao GR, Rao AR, Moorthy B, Rao TR (2009) Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin. Indian J Dermatol Venereol Leprol 75:268–271
Shah AA, Sinha AA (2013) Oxidative stress and autoimmune skin disease. Eur J Dermatol 23:5–13
Vaccaro M, Cannavò SP, Imbesi S, Cristani M, Barbuzza O, Tigano V, Gangemi S (2015) Increased serum levels of interleukin-23 circulating in patients with non-segmental generalized vitiligo. Int J Dermatol 54:672–674
Vaccaro M, Cicero F, Mannucci C, Calapai G, Spatari G, Barbuzza O, Cannavò SP, Gangemi S (2016) IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo. Arch Dermatol Res 308:527–530
Yildirim M, Baysal V, Inaloz HS, Kesici D, Delibas N (2003) The role of oxidants and antioxidants in generalized vitiligo. J Dermatol 30:104–108
Xie H, Zhou F, Liu L, Zhu G, Li Q, Li C, Gao T (2016) Vitiligo: how do oxidative stress-induced autoantigens trigger autoimmunity? J Dermatol Sci 81:3–9
Yazici C, Köse K, Utaş S, Tanrikulu E, Taşlidere N (2016) A novel approach in psoriasis: first usage of known protein oxidation markers to prove oxidative stress. Arch Dermatol Res 308:207–212
Zamani M, Spaepen M, Sghar SS, Huang C, Westerhof W, Nieuweboer-Krobotova L, Cassiman JJ (2001) Linkage and association of HLA class genes with vitiligo in a Dutch population. Br J Dermatol 145:90–94
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
All patients and controls gave their written informed consent before the enrollment.
Ethical approval
The study protocol was approved by local committee. All procedures performed in the study involving human participants were in accordance with the ethical standards.
Rights and permissions
About this article
Cite this article
Vaccaro, M., Bagnato, G., Cristani, M. et al. Oxidation products are increased in patients affected by non-segmental generalized vitiligo. Arch Dermatol Res 309, 485–490 (2017). https://doi.org/10.1007/s00403-017-1746-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-017-1746-z